Skip to content
Sentante logo — Sentante - the first fully-robotic teleoperated system for e...

Sentante

Sentante - the first fully-robotic teleoperated system for endovascular interventions

Founded 2017 Lithuania Lithuania 33 employees Seed Total: $8.55M

General Information

Company Name Sentante
Founded Year 2017
Location Lithuania Lithuania
Founders / Decision Makers
Team member Team member
Employees 33
Funding Stage Seed
Business Model B2B, D2C, B2D
Revenue Model Product Sales, Service Fee, Leasing/Rental
Social

BounceWatch is an independent company data service, not affiliated with Sentante. To contact Sentante, visit sentante.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sentante compare?

A PDF of Sentante and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sentante soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sentante

Sentante, established in 2017 and headquartered in Lithuania, is pioneering the realm of robotic-assisted medical interventions with its slogan: "Sentante - the first fully-robotic teleoperated system for endovascular interventions".

The core innovation of Sentante lies in its smart, sensory network, which enables remote execution of endovascular procedures. The system showcases a novel teleoperated robot that safeguards physicians from harmful X-ray exposure and introduces potential for tele-surgery. Its compatibility with conventional guidewires and catheters allows seamless operation using familiar tools. Additionally, the patented sensing technology offers real-time haptic feedback, simulating an in-person tactile experience.

Following a recent financial boost, Sentante secured a €6.00M Seed investment on December 1, 2023, from Practica Capital and the EIC Fund. This investment positions Sentante for accelerated growth in the advanced medical robotics market.

Business keywords: Robotic Surgery, Telemedicine, Endovascular Procedures, Telesurgery, Radiation Protection, Remote Surgery, Haptic Feedback Technology, Healthcare Robotics, Interventional Radiology, Guidewire Control, Catheter Navigation, Smart Robotics, Procedural Innovation, Physician Safety

Services & Products

Endovascular robotic procedures
Remote control of surgical interventions
Radiation protection for surgical staff
Surgical team workload optimization

Target Customers

Hospitals Cardiologists Interventional Radiologists Vascular Surgeons Healthcare Providers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed €6.00M 2
Practica Capital, EIC Fund
01 Dec 2023
Round Undisclosed 1
MedTech Innovator
01 Jun 2023
Early VC €2.50M 1
European Innovation Council
01 Jun 2021
Grant €50.00K -
01 Mar 2019

Sentante Alternatives & Competitors

Sentante vs

Steering your path towards micro-invasive procedures.

34 employees
Health Care, Industrial
Sentante vs
SOVATO
SOVATO United States

Sovato exists to make high-quality surgical care accessible anywhere.

Seed
38 employees
Health Care

FAQ About Sentante

Sentante - the first fully-robotic teleoperated system for endovascular interventions
Sentante was founded in 2017.
Sentante is headquartered in Lithuania.
Sentante has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Leasing/Rental.
Sentante has approximately 33 employees.
Sentante has completed 4 funding rounds, raising a total of $8.55M. The latest funding stage is Seed.
Sentante offers: Endovascular robotic procedures, Remote control of surgical interventions, Radiation protection for surgical staff, Surgical team workload optimization.
Top alternatives and competitors to Sentante include Interventional Systems, SOVATO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sentante and Interventional Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sentante, https://bouncewatch.com/company/sentante, updated 2 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout